Tekla Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.27M | Sell |
|
|||||
|
2023
Q1 | $2.49M | Hold |
|
|||||
|
2022
Q4 | $2.24M | Hold |
|
|||||
|
2022
Q3 | $3.6M | Hold |
|
|||||
|
2022
Q2 | $3.35M | Hold |
|
|||||
|
2022
Q1 | $3.46M | Hold |
|
|||||
|
2021
Q4 | $4.17M | Sell |
|
|||||
|
2021
Q3 | $18.2M | Hold |
|
|||||
|
2021
Q2 | $26.3M | Buy |
|
|||||
|
2021
Q1 | $18.4M | Buy |
|
|||||
|
2020
Q4 | $11.7M | Hold |
|
|||||
|
2020
Q3 | $6.38M | Hold |
|
|||||
|
2020
Q2 | $5.6M | Hold |
|
|||||
|
2020
Q1 | $3.23M | Hold |
|
|||||
|
2019
Q4 | $4.64M | Sell |
|
|||||
|
2019
Q3 | $4.15M | Sell |
|
|||||
|
2019
Q2 | $8.4M | Hold |
|
|||||
|
2019
Q1 | $6.37M | Hold |
|
|||||
|
2018
Q4 | $5.09M | Hold |
|
|||||
|
2018
Q3 | $7.91M | Hold |
|
|||||
|
2018
Q2 | $10.5M | Buy |
|
|||||
|
2018
Q1 | $6.45M | Buy |
|